Clinical trial
Benign Reproductive Tissue Analysis for Endometrial Cancer Markers
NCT00481754 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00481754 |
|---|---|
| Title | Benign Reproductive Tissue Analysis for Endometrial Cancer Markers |
| Official title | Benign Reproductive Tissue Evaluation (BRTE) Study |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Oophorectomy for Benign Reasons, Hysterectomy |
| Enrollment | 359 |
| Start date | Apr 24, 2006 |
| Primary completion | Nov 13, 2020 |
| Completion | Nov 13, 2020 |
| First posted | Jun 4, 2007 |
| Last update posted | Nov 17, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: